Tiêm chủng cho trẻ em và thanh thiếu niên mắc bệnh lý thấp khớp

Borchers AT, Selmi C, Cheema G et al. (2006) Juvenile idiopathic arthritis. Autoimmun Rev 5: 279–298 Gottlieb BS, Ilowite NT (2006) Systemic lupus erythematosus in children and adolescents. Pediatr Rev 27: 323–330 Minden K, Niewerth M, Ganser G et al. und Kinderrheumatologen der Gesellschaft für Kinder- und Jugendrheumatologie (2006) Die Kerndokumentation rheumakranker Kinder und Jugendlicher – Bilanz nach acht Jahren. Kinder- und Jugendmedizin 6: 312–317 Plotkin SA (2003) Vaccines, vaccination, and vaccinology. J Infect Dis 187: 1349–1359 Schattner A (2005) Consequence or coincidence? The occurrence, pathogenesis and significance of autoimmune manifestations after viral vaccines. Vaccine 23: 3876–3886 Fisher MA, Eklund SA, James SA, Lin X (2001) Adverse events associated with hepatitis B vaccine in U.S. children less than six years of age, 1993 and 1994. Ann Epidemiol 11: 13–21 Maillefert JF, Tonolli-Serabian I, Cherasse A et al. (2000) Arthritis following combined vaccine against diphtheria, polyomyelitis, and tetanus toxoid. Clin Exp Rheumatol 18: 255–256 Sebag O, Bolla G, Bebin B, Sebag F (1998) Exacerbation of chronic juvenile arthritis induced by hepatitis B vaccination. Arch Pediatr 5: 1046 Weibel RE, Benor DE (1996) Chronic arthropathy and musculoskeletal symptoms associated with rubella vaccines. A review of 124 claims submitted to the National Vaccine Injury Compensation Program. Arthritis Rheum 39: 1529–1534 CDC (1996) Measles pneumonitis following measles-mumps-rubella vaccination of a patient with HIA infection, 1993. MMWR 45: 603–606 Geiger R, Fink FM, Solder B et al. (1995) Persistent rubella infection after erroneous vaccination in an immunocompromised patient with acute lymphoblastic leukemia in remission. J Med Virol 47: 442–444 Mannhardt-Laakmann W, Knuf M, Umlauf V et al. (2005) Schutzimpfungen bei Kindern mit rheumatischen Erkrnakungen. Arthritis und Rheuma 2: 93–99 Meyer C, Rasch G,·Keller-Stanislawski B, Schnitzler N (2002) Anerkannte Impfschäden in der Bundesrepublik Deutschland 1990–1999. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 45: 364–370 Nakayama T, Onoda K (2007) Vaccine adverse events reported in post-marketing study of the Kitasato Institute from 1994 to 2004. Vaccine 25: 570–576 Bohlke K, Davis RL, Marcy SM et al. Vaccine Safety Datalink Team (2003) Risk of anaphylaxis after vaccination of children and adolescents. Pediatrics 112: 815–820 Empfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch-Institut (2006) Epidemiologisches Bulletin 28. Juli 2006; Nr. 30 (http://www.rki.de) Mitteilung der Ständigen Impfkommission (STIKO) am Robert Koch-Institut (2005) Hinweise zu Impfungen für Patienten mit Immundefizienz. Epidemiologisches Bulletin 10. November 2005; Nr. 39 (http://www.rki.de) Kroger AT, Atkinson WL, Marcuse EK, Pickering LK; Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC) (2006) General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 55 (RR-15): 1–48 Davies K, Woo P (2002) Immunisation in rheumatic diseases of childhood: an audit of the clinical practice of British Paediatric Rheumatology Group members and a review of the evidence. Rheumatology 41: 937–941 Dippelhofer A, Meyer C, Kamtsiuris P et al. (2002) Erste Ergebnisse zum Impfstatus aus der Pilotphase des Kinder- und Jugendgesundheitssurveys. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 45: 332–337 Smith PJ, Kennedy AM, Wooten K et al. (2006) Association between health care providers‘ influence on parents who have concerns about vaccine safety and vaccination coverage. Pediatrics 118: 1287–1292 Petty RE (1997) Viruses and childhood arthritis. Ann Med 29: 149–152 Fae KC, Oshiro SE, Toubert A et al. (2005) How an autoimmune reaction triggered by molecular mimicry between streptococcal M protein and cardiac tissue proteins leads to heart lesions in rheumatic heart disease. J Autoimmun 24: 101–109 Offit PA, Jew RK (2003) Addressing parents‘ concerns: do vaccines contain harmful preservatives, adjuvants, additives, or residuals? Pediatrics 112: 1394–1397 Maillefert JF, Sibilia J, Toussirot E et al. (1999) Rheumatic disorders developed after hepatitis B vaccination. Rheumatology (Oxford) 38: 978–983 Geier DA, Geier MR (2002) A one year follow up of chronic arthritis following rubella and hepatitis B vaccination based upon analysis of the Vaccine Adverse Events Reporting System (VAERS) database. Clin Exp Rheumatol 20: 767–771 Geier MR, Geier DA, Zahalsky AC (2003) Influenza vaccination and Guillain Barre syndrome small star, filled. Clin Immunol 107: 116–121 Geier DA, Geier MR (2006) A meta-analysis epidemiological assessment of neurodevelopmental disorders following vaccines administered from 1994 through 2000 in the United States. Neuro Endocrinol Lett 27: 401–413 Fisher MA, Eklund SA, James SA, Lin X (2001) Adverse events associated with hepatitis B vaccine in U.S. children less than six years of age, 1993 and 1994. Ann Epidemiol 11: 13–21 Geier MR, Geier DA (2004) A case-series of adverse events, positive re-challenge of symptoms, and events in identical twins following hepatitis B vaccination: analysis of the Vaccine Adverse Event Reporting System (VAERS) database and literature review. Clin Exp Rheumatol 22: 749–755 Tingle AJ, Allen M, Petty RE et al. (1986) Rubella-associated arthritis. I. Comparative study of joint manifestations associated with natural rubella infection and RA 27/3 rubella immunisation. Ann Rheum Dis 45: 110–114 Ada G (2001) Vaccines and vaccination. N Engl J Med 345: 1042–1053 Olson NY, Lindsley CB (1994) Influenza immunization in children with chronic arthritis. J Rheumatol 21: 1581–1582 Malleson PN, Tekano JL, Scheifele DW, Weber JM (1993) Influenza immunisation in children with chronic arthritis: a prospective study. J Rheumatol 20: 1769–1773 Kanakoudi-Tsakalidou F, Trachana M, Pratsidou-Gertsi P et al. (2001) Influenza vaccination in children with rheumatic diseases and long-term immunosuppressive therapy. Clin Exp Rheumatol 19: 589–594 Ronaghy A, Huijssoon E, van Rossum MA et al. (2003) Vaccination does not exacerbate juvenile idiopathic arthritis disease activity in a cohort of Dutch patients. Clin Exp Rheumatol 21 (Suppl): S535 Kasapcopur O, Cullu F, Kamburoglu-Goksel A et al. (2004) Hepatitis B vaccination in children with juvenile idiopathic arthritis. Ann Rheum Dis 63: 1128–1130 Elkayam O (2006) Safety and efficacy of vaccination against influenza in patients with rheumatoid arthritis. Clin Dev Immunol 13: 349–351 Kapetanovic MC, Saxne T, Sjoholm A et al. (2006) Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis. Rheumatology (Oxford) 45: 106–111 O’Neill SG, Isenberg DA (2006) Immunizing patients with systemic lupus erythematosus: a review of effectiveness and safety. Lupus 15: 778–783 Mease PJ, Ritchlin CT, Martin RW et al. (2004) Pneumococcal vaccine response in psoriatic arthritis patients during treatment with etanercept. J Rheumatol 31: 1356–1361 Elkayam O, Caspi D, Reitblatt T et al. (2004) The effect of tumor necrosis factor blockade on the response to pneumococcal vaccination in patients with rheumatoid arthritis and ankylosing spondylitis. Semin Arthritis Rheum 33: 283–288 Kapetanovic MC, Saxne T, Nilsson JA, Geborek P (2006) Influenza vaccination as model for testing immune modulation induced by anti-TNF and methotrexate therapy in rheumatoid arthritis patients. Rheumatology (Oxford) 2006 Nov 18 (Epub ahead of print) Molrine DC, Hibberd PL (2001) Vaccines for transplant recipients. Infect Dis Clin North Am 15: 273–305 Rose MA, Schubert R, Strnad N, Zielen S (2005) Priming of immunological memory by pneumococcal conjugate vaccine in children unresponsive to 23-valent polysaccharide pneumococcal vaccine. Clin Diagn Lab Immunol 12: 1216–1222 CDC (1998) Measles, mumps, and rubella – vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 47 (No. RR-8) CDC (1999) Prevention of varicella: update recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 48 (No. RR-6) Grossberg R, Harpaz R, Rubtcova E et al. (2006) Secondary transmission of varicella vaccine virus in a chronic care facility for children. J Pediatr 148: 842–844 CDC (2006) Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 55 (No. RR-12)